Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001511164-11-000125
Filing Date
2011-12-15
Accepted
2011-12-15 16:37:27
Documents
11
Period of Report
2011-10-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q neurokineform10qq3sept3011.htm 10-Q 254392
8 EXHIBIT 31.1 neurokinesection302certceoq3.htm EX-1 7731
9 EXHIBIT 31.2 neurokinesection302certcfoq3.htm EX-2 7815
10 EXHIBIT 32.1 neurokinesection906certceoq3.htm EX-3 5735
11 EXHIBIT 32.2 neurokinesection906certcfoq3.htm EX-4 5662
  Complete submission text file 0001511164-11-000125.txt   1384802

Data Files

Seq Description Document Type Size
2 EX-101 INSTANCE DOCUMENT neukf-20111031.xml EX-101.INS 153559
3 EX-101 SCHEMA DOCUMENT neukf-20111031.xsd EX-101.SCH 9829
4 EX-101 CALCULATION LINKBASE DOCUMENT neukf-20111031_cal.xml EX-101.CAL 5516
5 EX-101 DEFINITION LINKBASE neukf-20111031_def.xml EX-101.DEF 38793
6 EX-101 LABELS LINKBASE DOCUMENT neukf-20111031_lab.xml EX-101.LAB 77288
7 EX-101 PRESENTATION LINKBASE DOCUMENT neukf-20111031_pre.xml EX-101.PRE 57992
Mailing Address 1275 WEST 6TH AVENUE VANCOUVER A1 V6H 1A6
Business Address 1275 WEST 6TH AVENUE VANCOUVER A1 V6H 1A6 604 805 7783
Neurokine Pharmaceuticals Inc. (Filer) CIK: 0001464165 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 333-161157 | Film No.: 111263749
SIC: 2834 Pharmaceutical Preparations